United States v. Garcia-Contreras

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• finding that the statement “meeting 8 [with the FDA] . . . seemed to be very supportive” was not forward-looking”
• denying motion to strike expert report, but finding report \not essential to ... finding that Plaintiffs' complaint survives Defendants' motion to dismiss\
• denying motion to strike expert report, but finding report “not essential to . . . finding that Plaintiffs’ complaint survives Defendants’ motion to dismiss”
• finding the company’s “short-term need to keep their stock price above $6.50 per share provides a plausible motive for Defendants’ actions[] and supports a finding of scienter™
• finding scienter where defendant biopharma-ceutical company had claimed FDA “blessed” their study design
• refusing to dismiss claims where defendants claimed that the FDA had “blessed,” “approved,” “accepted,” and “agreed to” the company’s methodological approach in its clinical trials, when it later became evident that the FDA had not done so

Source: CourtListener parenthetical corpus (CC0).